The stock of Unity Biotechnology Inc (UBX) has gone down by -25.71% for the week, with a -32.99% drop in the past month and a 30.00% rise in the past quarter. The volatility ratio for the week is 9.52%, and the volatility levels for the past 30 days are 11.52% for UBX. The simple moving average for the last 20 days is -23.21% for UBX stock, with a simple moving average of -13.58% for the last 200 days.
Is It Worth Investing in Unity Biotechnology Inc (NASDAQ: UBX) Right Now?
Company’s 36-month beta value is 1.08.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for UBX is 15.38M, and currently, short sellers hold a 3.61% ratio of that floaft. The average trading volume of UBX on March 25, 2025 was 246.12K shares.
UBX) stock’s latest price update
Unity Biotechnology Inc (NASDAQ: UBX)’s stock price has plunge by -28.77relation to previous closing price of 1.83. Nevertheless, the company has seen a -25.71% plunge in its stock price over the last five trading sessions. benzinga.com reported 2025-03-24 that Unity Biotechnology, Inc. UBX stock plummeted on Monday after the company released results from its latest study.
Analysts’ Opinion of UBX
Many brokerage firms have already submitted their reports for UBX stocks, with Rodman & Renshaw repeating the rating for UBX by listing it as a “Buy.” The predicted price for UBX in the upcoming period, according to Rodman & Renshaw is $8 based on the research report published on August 22, 2024 of the previous year 2024.
Wedbush, on the other hand, stated in their research note that they expect to see UBX reach a price target of $4, previously predicting the price at $2. The rating they have provided for UBX stocks is “Outperform” according to the report published on November 16th, 2023.
UBX Trading at -31.71% from the 50-Day Moving Average
After a stumble in the market that brought UBX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.06% of loss for the given period.
Volatility was left at 11.52%, however, over the last 30 days, the volatility rate increased by 9.52%, as shares sank -28.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.26% lower at present.
During the last 5 trading sessions, UBX fell by -25.71%, which changed the moving average for the period of 200-days by -18.24% in comparison to the 20-day moving average, which settled at $1.6930. In addition, Unity Biotechnology Inc saw 33.14% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at UBX starting from Sullivan Lynne Marie, who sale 153 shares at the price of $2.23 back on Feb 04 ’25. After this action, Sullivan Lynne Marie now owns 55,772 shares of Unity Biotechnology Inc, valued at $341 using the latest closing price.
Nguyen Alexander Hieu, the CLO and Head of Ops of Unity Biotechnology Inc, sale 164 shares at $2.23 during a trade that took place back on Feb 04 ’25, which means that Nguyen Alexander Hieu is holding 24,559 shares at $366 based on the most recent closing price.
Stock Fundamentals for UBX
The total capital return value is set at -1.1. Equity return is now at value -148.97, with -48.99 for asset returns.
Based on Unity Biotechnology Inc (UBX), the company’s capital structure generated 0.78 points at debt to capital in total, while cash flow to debt ratio is standing at -0.89.
Currently, EBITDA for the company is -31.17 million with net debt to EBITDA at -0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.62.
Conclusion
In a nutshell, Unity Biotechnology Inc (UBX) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
